GDPD3 Deficiency Alleviates Neuropathic Pain and Reprograms Macrophagic Polarization Through PGE2 and PPARγ Pathway
Neurochemical Research · 2024
DOI: 10.1007/s11064-024-04148-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2024. Verfasst von Wenqian Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Dinoprostone, Macrophages, Mice, Inbred C57BL, Neuralgia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
The complex mechanism of neuropathic pain involves various aspects of both central and peripheral pain conduction pathways. An effective cure for neuropathic pain therefore remains elusive. We found that deficiency of the gene Gdpd3 , encoding a lysophospholipase D enzyme, alleviates the inflammatory responses in dorsal root ganglia (DRG) of mice under neuropathic pain and reduces PE (20:4) and PGE2 in DRG. Gdpd3 deficiency had a stronger analgesic effect on neuropathic pain than Celecoxib, a nonsteroidal anti-inflammatory drug. Gdpd3 deficiency also interferes with the polarization of macrophages, switching from M1 towards M2 phenotype. The PPARγ/ FABP4 pathway was screened by RNA sequencing as functional related with Gdpd3 deficient BMDMs stimulated with LPS. Both protein and mRNA levels of PPARγ in GDPD3 deficient BMDMs were higher than those of the litter control mice. However, GW9962 (inhibitor of PPARγ) could reverse the reprogramming polarization of macrophages caused by GDPD3 deficiency. Therefore, our study suggests that GDPD3 deficiency exerts a relieving effect on neuropathic pain and alleviates neuroinflammation in DRG by switching the phenotype of macrophages from M1 to M2, which was mediated through PGE2 and PPARγ/ FABP4 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, China.
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China. wu-qichao@outlook.com.
- Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, China. sally9132@163.com.
Förderung
- Research Project of Shanghai Municipal Health Commission
Zitieren
APA
Li, W., Fan, Y., Lan, H., Li, X., Wu, Q., & Dong, R. (2024). GDPD3 Deficiency Alleviates Neuropathic Pain and Reprograms Macrophagic Polarization Through PGE2 and PPARγ Pathway. Neurochemical Research. https://doi.org/10.1007/s11064-024-04148-2
Vancouver
Li W, Fan Y, Lan H, Li X, Wu Q, Dong R. GDPD3 Deficiency Alleviates Neuropathic Pain and Reprograms Macrophagic Polarization Through PGE2 and PPARγ Pathway. Neurochemical Research. 2024. doi:10.1007/s11064-024-04148-2
BibTeX
@article{Li2024,
author = {Li, Wenqian and Fan, Youjia and Lan, Haizhen and Li, Xiaoxiao and Wu, Qichao and Dong, Rong},
title = {GDPD3 Deficiency Alleviates Neuropathic Pain and Reprograms Macrophagic Polarization Through PGE2 and PPARγ Pathway},
journal = {Neurochemical Research},
year = {2024},
doi = {10.1007/s11064-024-04148-2}
}
EUVIMED